NeoCapCompaniesValuationsScenariosMetrics

IREN

IREN-🇦🇺 Australia
Price
$21.30
as of Nov 6, 2026
Market cap
$9.0B
as of Nov 6, 2026
Estimated total debt principal$10.89Bfacilities drawn: $413.0M of $1.50B
Trailing 12-month dilution+49.7%Oct 31, 2025 → Oct 30, 2026
Cash & equivalents$5.78Bas of Nov 5, 2026
Estimated cost of debt2.17%

Basic shares outstanding - Evolution

0141.5M282.9M424.4M214.4M224.5M272M283.5M332.3M357.4M394.1M424.4MDec '24Mar '25Aug '25Oct '25Jan '26Apr '26Aug '26Oct '26

Funding the build to end-2030

The Valuation tab's cash flows, year by year: capex for the fleet the guidance and the blocks give, at the pace the capex guidance sets for 2027; operating cash from that fleet at the run-rate the ARR guidance anchors, less taxes and the interest on today's debt.

Capex to fund$49.73bn3,011 MW to deliver · 2027 at the guided pace
Equity raised$5.52bn10% dilution a year
Debt to raise$14.12bn683.4m shares at end-2030

Sources and uses

YearCapexOperating cashCash usedEquity raisedDebt to raiseShares outClosing cash
2026from Oct$2.28bn$41m$2.24bn$904m · +42.4m—466.8m$5.53bn
2027$15bnguided$2.4bn$5.53bn$994m · +46.7m$6.08bn513.5m$0m
2028$17.62bn$8.48bn—$1.09bn · +51.3m$8.04bn564.8m$0m
2029$10.55bn$12.88bn—$1.2bn · +56.5m—621.3m$3.53bn
2030$4.28bn$15.46bn—$1.32bn · +62.1m—683.4m$16.04bn

Cash on hand is the balance sheet's cash plus committed undrawn facilities, capital closed since and customer prepayments. Equity at 10% of the share count a year at the latest close; the DCF charges the cost of the capital still to raise as its own line rather than growing the count. No deal records a customer prepayment yet — filling them in on the Deals tab cuts the raise dollar for dollar.

Debt stack

Secured notes

Total: $2.10B
InstrumentPrincipalRateMaturityStageSource
$2.10B
5.96%2031ClosedMay 29, 2026

Convertible notes

Total: $7.29B · net: $7.17B
InstrumentPrincipalRateReference priceConversion priceCapped callPrepaid forward repurchaseMaturityStageSource
$3.00Bnet $2.96B
1%
$55.15May 11, 2026
$73.07
$110.3
2033ClosedMay 14, 2026
$1.30Bnet $2.27B
1%
$41.12Dec 2, 2025
$51.4
$82.24
2033ClosedDec 8, 2025
$1.00B
0.25%
$41.12Dec 2, 2025
$51.4
$82.24
2032ClosedDec 8, 2025
$1.00Bnet $979.0M
Zero coupon
$60.09Oct 8, 2025
$85.63
$120.18
2031ClosedOct 14, 2025
$550.0Mnet $534.9M
3.5%
$10.49Jun 10, 2025
$13.64$92.5M2029ClosedJun 13, 2025
$440.0Mnet $425.4M
3.25%
$12.93Dec 3, 2024
$16.81
$25.86Cost $44.4M
$73.7M2030ClosedDec 6, 2024

Term loan / DDTL

Total: $1.50B
InstrumentPrincipalRateMaturityStageSource
$1.50B
2031ClosedMay 29, 2026

Equity & warrants

InstrumentDescriptionStatusSource
NVIDIA share purchase rightWarrants / purchase right
IREN granted a right to purchase up to 30,000,000 ordinary shares at $70 per share (~8.4% of basic shares outstanding at the time). The right expires May 7, 2031.
Ongoing
May 7, 2026
IREN authorized the sale of up to $6.00B of ordinary shares over time through an at-the-market program, at prevailing market prices.
Ongoing
Mar 4, 2026
IREN raised approximately $1.63B.
Closedas of Dec 8, 2025
Dec 3, 2025
IREN authorized the sale of up to $1.00B of ordinary shares over time through an at-the-market program, at prevailing market prices.
Supersededas of Mar 4, 2026
Jan 21, 2025
IREN authorized the sale of up to $100.0M of ordinary shares over time through an at-the-market program, at prevailing market prices.
Supersededas of Jan 21, 2025
Sep 23, 2022
IREN raised approximately $231.5M.
Closedas of Nov 17, 2021
Nov 17, 2021

Other instruments